Xenon Pharmaceuticals Inc.
XENENasdaqCIK 1582313HealthcareFiscal year ends Dec 31
Reports and events: 210 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-0620:31 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-338244 |
| 2026-08-0620:11 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-338019 |
| 2026-06-0320:02 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-255396 |
| 2026-05-0720:35 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-212153 |
| 2026-05-0720:02 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-211843 |
| 2026-04-2220:02 ET | DEF 14A | Proxy statementPeriod 2026-04-22 | 0001193125-26-170320 |
| 2026-04-1320:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-152834 |
| 2026-03-1320:10 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-106144 |
| 2026-03-1220:17 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-104199 |
| 2026-03-0911:36 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-097577 |
| 2026-02-2721:03 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-082520 |
| 2026-02-2621:12 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-076650 |
| 2026-02-2621:03 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-076530 |
| 2025-12-0121:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-25-303862 |
| 2025-11-0321:31 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-262646 |
| 2025-11-0321:04 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-262519 |
| 2025-10-1720:37 ET | 8-K/A | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-242583 |
| 2025-10-1621:16 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-25-241546 |
| 2025-08-1120:32 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-106599 |
| 2025-08-1120:04 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-106529 |
| 2025-07-0321:22 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-25-093996 |
| 2025-06-0521:07 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-25-082494 |
| 2025-05-1220:40 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-069342 |
| 2025-05-1220:07 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-069183 |
| 2025-04-2420:22 ET | DEF 14A | Proxy statementPeriod 2025-04-24 | 0000950170-25-058086 |
| 2025-03-1720:39 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-040381 |
| 2025-03-0521:25 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0000950170-25-033653 |
| 2025-02-2721:39 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-029149 |
| 2025-02-2721:04 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-029010 |
| 2025-01-1714:01 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-25-006495 |
| 2024-11-1221:36 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-125547 |
| 2024-11-1221:09 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-125374 |
| 2024-08-0820:36 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-094109 |
| 2024-08-0820:08 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-093933 |
| 2024-06-0520:12 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-24-069318 |
| 2024-05-0920:35 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-057139 |
| 2024-05-0920:09 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-056940 |
| 2024-04-2620:26 ET | DEF 14A | Proxy statementPeriod 2024-04-26 | 0000950170-24-049198 |
| 2024-04-1920:21 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-24-046023 |
| 2024-03-0822:27 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-028784 |
| 2024-02-2921:36 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000950170-24-023177 |
| 2024-02-2921:10 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-023080 |
| 2023-11-3021:15 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-23-067040 |
| 2023-11-2712:03 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-23-066032 |
| 2023-11-0921:06 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-23-062022 |
| 2023-11-0821:36 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0000950170-23-061200 |
| 2023-11-0821:11 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-23-061119 |
| 2023-08-0920:38 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0000950170-23-040681 |
| 2023-08-0920:16 ET | 8-K | 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-23-040608 |
| 2023-08-0820:07 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-23-039782 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:14 ET. Listed shows no prices and gives no investment advice.